Selected article for: "pulmonary hypertension and tricuspid regurgitation"

Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
  • ID: roslkxeq_60
    Snippet: Sixteen client-owned dogs with proven moderate-to-severe pulmonary hypertension were randomly assigned to the treatment (n = 8; ozagrel hydrochloride, 5 mg/kg bid PO) or control group (n = 8; sildenafil citrate, 1 mg/kg bid PO). All patients have already been treated with standard protocol including sildenafil (1.8 AE 0.6 mg/kg, bid). Pulmonary hypertension associated with left-side heart failure (LA/Ao >1.6 and LVIDDn >1.7) was excluded in the p.....
    Document: Sixteen client-owned dogs with proven moderate-to-severe pulmonary hypertension were randomly assigned to the treatment (n = 8; ozagrel hydrochloride, 5 mg/kg bid PO) or control group (n = 8; sildenafil citrate, 1 mg/kg bid PO). All patients have already been treated with standard protocol including sildenafil (1.8 AE 0.6 mg/kg, bid). Pulmonary hypertension associated with left-side heart failure (LA/Ao >1.6 and LVIDDn >1.7) was excluded in the population. Several clinical indices, which relate to hypoxia (lactate, SpO 2 , base excess), thrombosis (d-dimer), azotemia (BUN, creatinine), congestion (NT-proBNP) and echocardiographic indices (peak velocity of tricuspid regurgitation, Ao/ MPA), were tracked down for four weeks.

    Search related documents:
    Co phrase search for related documents
    • base excess and control group: 1, 2, 3, 4, 5, 6
    • base excess and heart failure: 1, 2, 3
    • clinical index and control group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • clinical index and echocardiographic index: 1
    • clinical index and heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • control group and heart failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • echocardiographic index and heart failure: 1